Connor, Clark & Lunn Investment Management (CC&L)’s CASI Pharmaceuticals CASI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,761
Closed -$22K 1049
2021
Q4
$22K Sell
2,761
-3,329
-55% -$26.5K ﹤0.01% 1056
2021
Q3
$72K Buy
+6,090
New +$72K ﹤0.01% 1000